
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Revenue | $238.6M | $274.9M | $303M | $344.4M | $408.1M | |
Revenue Growth (YoY) | -2.14% | 15.2% | 10.2% | 13.69% | 18.48% | |
Cost of Revenues | $153.9M | $172.3M | $193.7M | $222.1M | $263.4M | |
Gross Profit | $84.7M | $102.6M | $109.2M | $122.4M | $144.7M | |
Gross Profit Margin | 35.49% | 37.33% | 36.06% | 35.53% | 35.47% | |
R&D Expenses | $19.3M | $21.8M | $22.6M | $24.9M | $36.4M | |
Selling, General & Admin | $58M | $56.3M | $57.7M | $69.8M | $85M | |
Other Inc / (Exp) | -$3.7M | -$2M | $1.3M | -$5.8M | -$4M | |
Operating Expenses | $77.3M | $78.1M | $80.3M | $94.8M | $121.5M | |
Operating Income | $7.4M | $24.5M | $29M | $27.6M | $23.3M | |
Net Interest Expenses | -- | -- | -- | $532K | $2.3M | |
EBT. Incl. Unusual Items | $3.7M | $22.4M | $30.4M | $21.3M | $16.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.5M | -$87.7M | $9.3M | $11.1M | $6.1M | |
Net Income to Company | $257K | $110.1M | $21.2M | $10.2M | $10.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $257K | $110.1M | $21.2M | $10.2M | $10.8M | |
Basic EPS (Cont. Ops) | $0.02 | $9.98 | $1.89 | $0.90 | $0.88 | |
Diluted EPS (Cont. Ops) | $0.02 | $9.42 | $1.79 | $0.86 | $0.86 | |
Weighted Average Basic Share | $10.8M | $11M | $11.2M | $11.4M | $12.2M | |
Weighted Average Diluted Share | $10.9M | $11.7M | $11.8M | $11.9M | $12.5M | |
EBITDA | $11.8M | $29.9M | $33.4M | $33.8M | $28.3M | |
EBIT | $7.4M | $24.5M | $29M | $27.6M | $23.3M | |
Revenue (Reported) | $238.6M | $274.9M | $303M | $344.4M | $408.1M | |
Operating Income (Reported) | $7.4M | $24.5M | $29M | $27.6M | $23.3M | |
Operating Income (Adjusted) | $7.4M | $24.5M | $29M | $27.6M | $23.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $66.4M | $74.5M | $83.5M | $110.8M | $112.6M | |
Revenue Growth (YoY) | 8.19% | 12.22% | 12.03% | 32.75% | 1.64% | |
Cost of Revenues | $40.8M | $47M | $53.6M | $74.8M | $73.3M | |
Gross Profit | $25.6M | $27.5M | $29.8M | $36.1M | $39.3M | |
Gross Profit Margin | 38.52% | 36.95% | 35.74% | 32.55% | 34.89% | |
R&D Expenses | $5.3M | $5.3M | $6.5M | $10.6M | $7.7M | |
Selling, General & Admin | $15.1M | $14.9M | $15.8M | $20.2M | $22.1M | |
Other Inc / (Exp) | -$1M | -$103K | -$283K | $354K | -$3.2M | |
Operating Expenses | $20.4M | $20.1M | $22.4M | $30.8M | $29.8M | |
Operating Income | $5.2M | $7.4M | $7.5M | $5.3M | $9.5M | |
Net Interest Expenses | -- | -- | $122K | $928K | $1.6M | |
EBT. Incl. Unusual Items | $4.2M | $7.3M | $7.1M | $4.7M | $4.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$90.6M | $1.3M | $2.2M | $806K | $1.1M | |
Net Income to Company | $94.7M | $6M | $4.9M | $3.9M | $3.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $94.7M | $6M | $4.9M | $3.9M | $3.5M | |
Basic EPS (Cont. Ops) | $8.49 | $0.54 | $0.43 | $0.31 | $0.28 | |
Diluted EPS (Cont. Ops) | $8.00 | $0.51 | $0.41 | $0.30 | $0.27 | |
Weighted Average Basic Share | $11.2M | $11.2M | $11.4M | $12.6M | $12.7M | |
Weighted Average Diluted Share | $11.8M | $11.8M | $11.9M | $12.8M | $12.8M | |
EBITDA | $6.6M | $8.5M | $8.7M | $6.8M | $8.1M | |
EBIT | $5.2M | $7.4M | $7.2M | $5.6M | $6.2M | |
Revenue (Reported) | $66.4M | $74.5M | $83.5M | $110.8M | $112.6M | |
Operating Income (Reported) | $5.2M | $7.4M | $7.5M | $5.3M | $9.5M | |
Operating Income (Adjusted) | $5.2M | $7.4M | $7.2M | $5.6M | $6.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $265.9M | $297.2M | $332.8M | $380.4M | $435.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $167.3M | $189.6M | $213.9M | $246M | $294.8M | |
Gross Profit | $98.6M | $107.7M | $119M | $134.5M | $141.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $19.8M | $23.6M | $23.9M | $31.7M | $39.3M | |
Selling, General & Admin | $55.2M | $56.1M | $66.3M | $81.9M | $91.4M | |
Other Inc / (Exp) | -$2.5M | -$1.1M | -$4.2M | -$2.8M | -$7.2M | |
Operating Expenses | $75M | $79.7M | $90.2M | $113.6M | $130.7M | |
Operating Income | $23.6M | $28M | $28.8M | $20.9M | $10.4M | |
Net Interest Expenses | -- | -- | $122K | $1.7M | $5.2M | |
EBT. Incl. Unusual Items | $20.8M | $26.9M | $24.7M | $16.3M | -$2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$87.6M | $7.4M | $11.9M | $5.1M | $313K | |
Net Income to Company | $108.5M | $19.5M | $12.7M | $11.2M | -$2.3M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $108.5M | $19.5M | $12.7M | $11.2M | -$2.3M | |
Basic EPS (Cont. Ops) | $9.75 | $1.73 | $1.12 | $1.06 | -$0.19 | |
Diluted EPS (Cont. Ops) | $9.23 | $1.63 | $1.06 | $1.03 | -$0.20 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $30.7M | $32.8M | $34.1M | $30.6M | $15.1M | |
EBIT | $25.5M | $28M | $28.5M | $25.2M | $7.9M | |
Revenue (Reported) | $265.9M | $297.2M | $332.8M | $380.4M | $435.9M | |
Operating Income (Reported) | $23.6M | $28M | $28.8M | $20.9M | $10.4M | |
Operating Income (Adjusted) | $25.5M | $28M | $28.5M | $25.2M | $7.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $203.2M | $225.5M | $255.4M | $291.4M | $319.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $126.5M | $143.8M | $163.9M | $187.8M | $219.3M | |
Gross Profit | $76.7M | $81.8M | $91.5M | $103.6M | $100M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $15.5M | $17.3M | $18.7M | $25.4M | $28.3M | |
Selling, General & Admin | $41.6M | $41.3M | $49.9M | $62M | $68.3M | |
Other Inc / (Exp) | -$996K | -$14K | -$5.5M | -$2.5M | -$5.6M | |
Operating Expenses | $57.1M | $58.6M | $68.6M | $87.4M | $96.7M | |
Operating Income | $19.6M | $23.1M | $22.9M | $16.2M | $3.3M | |
Net Interest Expenses | -- | -- | $122K | $1.4M | $4.3M | |
EBT. Incl. Unusual Items | $18.7M | $23.1M | $17.3M | $12.3M | -$6.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$88.6M | $6.5M | $9.1M | $3.1M | -$2.7M | |
Net Income to Company | $107.3M | $16.6M | $8.2M | $9.2M | -$3.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $107.3M | $16.6M | $8.2M | $9.2M | -$3.9M | |
Basic EPS (Cont. Ops) | $9.64 | $1.48 | $0.71 | $0.77 | -$0.31 | |
Diluted EPS (Cont. Ops) | $9.12 | $1.39 | $0.67 | $0.75 | -$0.32 | |
Weighted Average Basic Share | $33M | $33.6M | $34M | $36.1M | $38M | |
Weighted Average Diluted Share | $34.4M | $35.7M | $34.9M | $37M | $38.3M | |
EBITDA | $23.7M | $26.6M | $27.2M | $18.9M | $4.3M | |
EBIT | $19.6M | $23.1M | $22.7M | $15.2M | -$1.6M | |
Revenue (Reported) | $203.2M | $225.5M | $255.4M | $291.4M | $319.3M | |
Operating Income (Reported) | $19.6M | $23.1M | $22.9M | $16.2M | $3.3M | |
Operating Income (Adjusted) | $19.6M | $23.1M | $22.7M | $15.2M | -$1.6M |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $41.6M | $47.9M | $36.9M | $22.2M | $64.6M | |
Short Term Investments | -- | -- | $10.9M | -- | -- | |
Accounts Receivable, Net | $44.7M | $48.1M | $73.2M | $100.9M | $158M | |
Inventory | $15.2M | $24.9M | $27.2M | $33.4M | $62.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $10.4M | $9.6M | $12.4M | $13.3M | $13.6M | |
Total Current Assets | $140M | $170.2M | $206.4M | $235.9M | $405.2M | |
Property Plant And Equipment | $20.4M | $15.5M | $11.6M | $12M | $13.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | $5.1M | $8.2M | |
Other Intangibles | -- | -- | -- | $9M | $13.6M | |
Other Long-Term Assets | $6.7M | $8.4M | $10.4M | $14M | $11.8M | |
Total Assets | $179.8M | $297.7M | $323.9M | $363.1M | $535.2M | |
Accounts Payable | $32M | $32.4M | $42.4M | $60.1M | $92.9M | |
Accrued Expenses | $15.1M | $14.7M | $14.8M | $9.5M | $23.6M | |
Current Portion Of Long-Term Debt | $9M | -- | -- | -- | $2.4M | |
Current Portion Of Capital Lease Obligations | $1.4M | $769K | $513K | $610K | $1M | |
Other Current Liabilities | $2.7M | $2.7M | $1.4M | $600K | $21.6M | |
Total Current Liabilities | $94M | $96.4M | $104.5M | $130.1M | $218.9M | |
Long-Term Debt | -- | -- | -- | -- | $46M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $111.1M | $114.3M | $122.2M | $144.4M | $279.3M | |
Common Stock | $108K | $112K | $112K | $115K | $126K | |
Other Common Equity Adj | -$15M | -$14.3M | -$16M | -$16M | -$19.3M | |
Common Equity | $68.7M | $183.3M | $201.8M | $218.7M | $255.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $68.7M | $183.3M | $201.8M | $218.7M | $255.9M | |
Total Liabilities and Equity | $179.8M | $297.7M | $323.9M | $363.1M | $535.2M | |
Cash and Short Terms | $41.6M | $47.9M | $47.8M | $22.2M | $64.6M | |
Total Debt | $9M | -- | -- | -- | $48.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $45.8M | $31.3M | $22.5M | $58.2M | $49.4M | |
Short Term Investments | -- | -- | -- | $988K | -- | |
Accounts Receivable, Net | $47.6M | $76.2M | $88.5M | $138.4M | $178M | |
Inventory | $23.1M | $30.5M | $40.9M | $56.8M | $93.2M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $7.7M | $13M | $21.3M | $13.2M | $14.5M | |
Total Current Assets | $164.3M | $196.6M | $236.5M | $362.5M | $456.6M | |
Property Plant And Equipment | $15.5M | $12.7M | $13.2M | $9.4M | $19M | |
Long-Term Investments | -- | $2.5M | -- | -- | -- | |
Goodwill | -- | -- | $5M | $8.2M | $19.2M | |
Other Intangibles | -- | -- | $6.9M | $14M | $26.8M | |
Other Long-Term Assets | $8.3M | $9.8M | $14.3M | $11.7M | $14.3M | |
Total Assets | $290.6M | $319.7M | $364.7M | $490.3M | $628.3M | |
Accounts Payable | $37.2M | $40.6M | $61.7M | $64.6M | $137.7M | |
Accrued Expenses | $15M | $16.5M | $15.3M | $19.3M | $19.3M | |
Current Portion Of Long-Term Debt | -- | -- | $6.2M | $2.4M | $3.7M | |
Current Portion Of Capital Lease Obligations | $754K | $565K | $721K | $780K | $1.2M | |
Other Current Liabilities | $2M | $999K | $884K | $22.7M | $13.3M | |
Total Current Liabilities | $93.7M | $105.7M | $133.2M | $171.1M | $282.1M | |
Long-Term Debt | -- | -- | -- | $46.6M | $70.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $110.9M | $122.4M | $149.3M | $231.8M | $372.2M | |
Common Stock | $112K | $112K | $114K | $126K | $127K | |
Other Common Equity Adj | -$14.7M | -$15.4M | -$15.8M | -$15.8M | -$19.5M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $179.7M | $197.3M | $215.4M | $258.5M | $256.1M | |
Total Liabilities and Equity | $290.6M | $319.7M | $364.7M | $490.3M | $628.3M | |
Cash and Short Terms | $45.8M | $31.3M | $22.5M | $59.2M | $49.4M | |
Total Debt | -- | -- | $6.2M | $48.9M | $73.9M |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $257K | $110.1M | $21.2M | $10.2M | $10.8M | |
Depreciation & Amoritzation | $4.4M | $5.4M | $4.5M | $6.2M | $5M | |
Stock-Based Compensation | $1.7M | $2.9M | $3.8M | $6.7M | $7.3M | |
Change in Accounts Receivable | $6.7M | -$12.8M | -$34.4M | -$37.2M | -$44.1M | |
Change in Inventories | -$6.7M | -$11.1M | -$3.9M | -$4.9M | $1.6M | |
Cash From Operations | $17.5M | $17.3M | $2.8M | -$1.6M | $30.5M | |
Capital Expenditures | $4.6M | $2.8M | $1.8M | $5.3M | $2.7M | |
Cash Acquisitions | -- | -- | -- | -$15.8M | -$32.2M | |
Cash From Investing | -$4.6M | -$2.8M | -$7.8M | -$11.9M | -$35.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $41.9M | -- | -- | $102.2M | $83.2M | |
Long-Term Debt Repaid | -$41.9M | -$9M | -- | -$102.2M | -$34.5M | |
Repurchase of Common Stock | -$1.8M | -$787K | -$5.4M | -- | -$332K | |
Other Financing Activities | -$802K | -$167K | -$541K | -$2M | -$775K | |
Cash From Financing | -$2.5M | -$8M | -$4.9M | -$681K | $48.7M | |
Beginning Cash (CF) | $32.2M | $41.9M | $48.2M | $37.1M | $22.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $10.3M | $6.4M | -$9.9M | -$14.3M | $44M | |
Ending Cash (CF) | $41.9M | $48.2M | $37.1M | $22.5M | $64.9M | |
Levered Free Cash Flow | $12.9M | $14.5M | $997K | -$7M | $27.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $94.7M | $6M | $4.9M | $3.9M | $3.5M | |
Depreciation & Amoritzation | $1.4M | $1.1M | $1.6M | $1.2M | $1.8M | |
Stock-Based Compensation | $765K | $840K | $1.6M | $1.9M | $2M | |
Change in Accounts Receivable | -$10.7M | -$10.1M | -$7.1M | $13.8M | -$19.1M | |
Change in Inventories | -$4.9M | -$3.6M | -$4.4M | $6M | -$17M | |
Cash From Operations | $4M | -$8.6M | -$646K | $15.3M | $1.6M | |
Capital Expenditures | $1M | $230K | $4.4M | $497K | $2.8M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1M | -$438K | -$4.4M | -$1.4M | -$2.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $26.2M | -- | $20M | |
Long-Term Debt Repaid | -- | -- | -$20M | -$625K | -$20.9M | |
Repurchase of Common Stock | -$458K | -$2M | -- | -- | -$99K | |
Other Financing Activities | $1K | -- | -$366K | -$567K | -$56K | |
Cash From Financing | -$54K | -$1.6M | $6.2M | -$1M | -$1M | |
Beginning Cash (CF) | $43.3M | $42.6M | $21.6M | $46.2M | $53.5M | |
Foreign Exchange Rate Adjustment | -$126K | -$372K | -$32K | -$594K | $388K | |
Additions / Reductions | $2.9M | -$10.7M | $1.1M | $12.9M | -$2.2M | |
Ending Cash (CF) | $46.1M | $31.5M | $22.7M | $58.5M | $51.7M | |
Levered Free Cash Flow | $2.9M | -$8.9M | -$5M | $14.8M | -$1.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $108.5M | $19.5M | $12.7M | $11.2M | -$2.3M | |
Depreciation & Amoritzation | $5.2M | $4.8M | $5.6M | $5.3M | $7.2M | |
Stock-Based Compensation | $2.5M | $3.2M | $6.5M | $7.1M | $7.4M | |
Change in Accounts Receivable | -$19.8M | -$30.6M | -$27.7M | -$7.2M | -$80.8M | |
Change in Inventories | -$9M | -$8.7M | -$7.1M | $11M | -$35.3M | |
Cash From Operations | $17.1M | -$7.7M | $4.6M | $29.6M | $3.5M | |
Capital Expenditures | $3.1M | $1.5M | $5.8M | $2.1M | $11.5M | |
Cash Acquisitions | -- | -- | -$15.8M | -$32.2M | -$18.1M | |
Cash From Investing | -$3.1M | -$1.7M | -$18.2M | -$35.2M | -$26.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $50.2M | $135.2M | $130M | |
Long-Term Debt Repaid | -$23.9M | -- | -$44M | -$92M | -$105.3M | |
Repurchase of Common Stock | -$458K | -$4.9M | -- | -- | -- | |
Other Financing Activities | -$205K | -$358K | -$1.2M | -$1.7M | -$7.3M | |
Cash From Financing | -$7.8M | -$4.4M | $5.4M | $42.4M | $17M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $6.2M | -$13.7M | -$8.3M | $36.7M | -$6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $14M | -$9.2M | -$1.2M | $27.4M | -$8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $107.3M | $16.6M | $8.2M | $9.2M | -$3.9M | |
Depreciation & Amoritzation | $4M | $3.4M | $4.6M | $3.7M | $5.9M | |
Stock-Based Compensation | $2.2M | $2.5M | $5.1M | $5.5M | $5.6M | |
Change in Accounts Receivable | -$18.9M | -$36.7M | -$29.9M | $65K | -$36.6M | |
Change in Inventories | -$9M | -$6.7M | -$9.9M | $6M | -$30.9M | |
Cash From Operations | $14.2M | -$10.8M | -$9M | $22.2M | -$4.8M | |
Capital Expenditures | $2.4M | $1M | $5.1M | $1.9M | $10.7M | |
Cash Acquisitions | -- | -- | -$15.8M | -$32.2M | -$18.2M | |
Cash From Investing | -$2.4M | -$1.2M | -$11.7M | -$35M | -$26.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $50.2M | $83.2M | $130M | |
Long-Term Debt Repaid | -$9M | -- | -$44M | -$33.8M | -$104.7M | |
Repurchase of Common Stock | -$458K | -$4.6M | -- | -$332K | -$598K | |
Other Financing Activities | -$167K | -$358K | -$1.1M | -$769K | -$7.3M | |
Cash From Financing | -$7.7M | -$4M | $6.2M | $49.3M | $17.6M | |
Beginning Cash (CF) | $121.7M | $138.3M | $80.5M | $104.5M | $170.6M | |
Foreign Exchange Rate Adjustment | $140K | -$663K | $9K | -$597K | $214K | |
Additions / Reductions | $4.1M | -$16.1M | -$14.4M | $36.6M | -$13.5M | |
Ending Cash (CF) | $125.8M | $121.6M | $66M | $140.4M | $157.3M | |
Levered Free Cash Flow | $11.8M | -$11.8M | -$14.1M | $20.4M | -$15.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.